Related Experiment Videos
Microalbuminuria in essential hypertension
1Department of Nephrology, Sahlgrenska Hospital, University of Gothenburg, Sweden.
Abstract:
Clinically apparent proteinuria in essential hypertension is associated with increased cardiovascular and total mortality and is an independent risk factor for cardiovascular and cerebrovascular disease. Subclinical elevation of urinary albumin excretion is seen more frequently than clinical proteinuria in essential hypertension and the levels of microalbuminuria (excretions of 30 to 300 mg/24 h) correlate with blood pressure. The increased urinary albumin excretion in hypertension may be explained by several factors such as renal hemodynamic changes, permselectivity changes of the glomerular filter, and structural arteriolar and glomerular changes due to nephrosclerosis. It has been clearly demonstrated that microalbuminuria is a risk factor for the development of clinical proteinuria, renal failure and increased cardiovascular mortality in insulin-dependent diabetes mellitus. It is still not known whether microalbuminuria also predicts development of proteinuria and decline in renal function in hypertension but there is some evidence indicating that microalbuminuria may be a marker of increased cardiovascular risk in hypertensives.
Insights
Microalbuminuria, a marker of early kidney damage, is common in hypertension and linked to higher cardiovascular risk. Further research is needed to confirm if it predicts kidney decline in hypertensive patients.
Area of Science:
- Nephrology
- Cardiology
- Hypertension Research
Background:
- Clinically apparent proteinuria in essential hypertension signifies increased mortality and is a risk factor for cardiovascular and cerebrovascular diseases.
- Subclinical microalbuminuria (30-300 mg/24 h urinary albumin excretion) is more frequent than clinical proteinuria in hypertension and correlates with blood pressure.
- Increased urinary albumin excretion in hypertension may stem from renal hemodynamic changes, altered glomerular permselectivity, and structural changes due to nephrosclerosis.
Purpose of the Study:
- To investigate the role of microalbuminuria as a predictor of proteinuria and renal function decline in essential hypertension.
- To explore microalbuminuria as a potential marker of increased cardiovascular risk in hypertensive individuals.
Main Methods:
- The study reviews existing evidence on microalbuminuria and its association with hypertension.
- Analysis of factors contributing to increased urinary albumin excretion in hypertensive patients.
- Comparison of microalbuminuria's predictive value in hypertension versus diabetes mellitus.
Main Results:
- Microalbuminuria is a known risk factor for proteinuria, renal failure, and cardiovascular mortality in diabetes mellitus.
- Evidence suggests microalbuminuria may serve as a marker for increased cardiovascular risk in hypertensive patients.
- The predictive value of microalbuminuria for proteinuria and renal function decline in hypertension remains under investigation.
Conclusions:
- Microalbuminuria is frequently observed in essential hypertension and is associated with elevated blood pressure.
- While established as a risk factor in diabetes, its role in predicting renal and cardiovascular outcomes in hypertension requires further elucidation.
- Microalbuminuria may indicate heightened cardiovascular risk in hypertensive individuals, warranting closer monitoring.